NYSE: IBTAIbotta Inc Stock
$22.73+0.40 (+1.79%)
Updated Dec 31, 2025
IBTA Price
$22.73
Fair Value Price
N/A
Market Cap
$604.23M
52 Week Low
$20.60
52 Week High
$76.00
P/E
6.79x
P/B
1.83x
P/S
2.21x
PEG
0.21x
Dividend Yield
N/A
Revenue
$352.24M
Earnings
$80.75M
Gross Margin
80.9%
Operating Margin
5.34%
Profit Margin
22.9%
Debt to Equity
0.73
Operating Cash Flow
$89M
Beta
1.25
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine IBTA's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: App
Industry Rating
B
IBTA
Ranked#140 of 180
Ranked#140 of 180
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $67.89 | A | |
| $28.88 | A | |
| $4.12 | A |
Be the first to know about important IBTA news, forecast changes, insider trades & much more!
IBTA News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IBTA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IBTA ($22.73) is trading below its intrinsic value of $60.39, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IBTA is good value based on its earnings relative to its share price (6.79x), compared to the US market average (43.84x)
P/E vs Market Valuation
IBTA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more IBTA due diligence checks available for Premium users.
Valuation
IBTA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
6.79x
Industry
-0.62x
Market
43.84x
IBTA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IBTA is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
IBTA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.83x
Industry
0.01x
IBTA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
IBTA price to earnings growth (PEG)
For valuing profitable companies with growth potential
IBTA is good value based... subscribe to Premium to read more.
PEG Value Valuation
IBTA's financial health
Profit margin
Revenue
$83.3M
Net Income
$1.5M
Profit Margin
1.8%
IBTA's Earnings (EBIT) of $18.81M... subscribe to Premium to read more.
Interest Coverage Financials
IBTA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$569.4M
Liabilities
$239.8M
Debt to equity
0.73
IBTA's short-term assets ($455.46M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IBTA's short-term assets ($455.46M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IBTA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$21.8M
Investing
-$11.2M
Financing
-$37.8M
IBTA's operating cash flow ($89.46M)... subscribe to Premium to read more.
Debt Coverage Financials
IBTA vs App Stocks
Ibotta Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.